Metformin for antipsychotic-related weight gain and metabolic abnormalities: when, for whom, and for how long?
- PMID: 24030606
- DOI: 10.1176/appi.ajp.2013.13060771
Metformin for antipsychotic-related weight gain and metabolic abnormalities: when, for whom, and for how long?
Comment in
-
Metformin and Alzheimer's disease risk.Am J Psychiatry. 2014 Jan;171(1):119. doi: 10.1176/appi.ajp.2013.13091193. Am J Psychiatry. 2014. PMID: 24399432 No abstract available.
Comment on
-
Metformin for weight loss and metabolic control in overweight outpatients with schizophrenia and schizoaffective disorder.Am J Psychiatry. 2013 Sep;170(9):1032-40. doi: 10.1176/appi.ajp.2013.12010127. Am J Psychiatry. 2013. PMID: 23846733 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
